Suvretta Capital Management, LLC 89bio, Inc. Transaction History
Suvretta Capital Management, LLC
- $2.91 Billion
- Q2 2025
A detailed history of Suvretta Capital Management, LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 14,210,000 shares of ETNB stock, worth $115 Million. This represents 4.8% of its overall portfolio holdings.
Number of Shares
14,210,000
Previous 14,335,244
0.87%
Holding current value
$115 Million
Previous $104 Million
33.9%
% of portfolio
4.8%
Previous 4.56%
Shares
10 transactions
Others Institutions Holding ETNB
# of Institutions
214Shares Held
162MCall Options Held
299KPut Options Held
1.61M-
Janus Henderson Group PLC London, X020.8MShares$168 Million0.11% of portfolio
-
Ra Capital Management, L.P. Boston, MA19.9MShares$161 Million4.27% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.5MShares$76.8 Million3.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.24MShares$66.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$56.7 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $376M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...